Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
August 10, 2023	NT 10-Q	Notification that form type 10-Q will be submitted late	0001517022-23-000025.pdf 0001517022-23-000025.rtf 0001517022-23-000025.xls View HTML
March 1, 2022	POS AM	Post-effective amendment to an S-Type filing	0001193125-22-061620.pdf 0001193125-22-061620.rtf 0001193125-22-061620.xls View HTML
March 1, 2022	POSASR	POSASR	0001193125-22-061326.pdf 0001193125-22-061326.rtf 0001193125-22-061326.xls View HTML
April 10, 2020	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001193125-20-103794.pdf 0001193125-20-103794.rtf 0001193125-20-103794.xls View HTML
February 17, 2023	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001193125-23-042106.pdf 0001193125-23-042106.rtf 0001193125-23-042106.xls View HTML
April 15, 2020	PRER14A	Proxy soliciting materials. Revised preliminary material	0001193125-20-107370.pdf 0001193125-20-107370.rtf 0001193125-20-107370.xls View HTML
February 14, 2014	S-1	Registration statement for face-amount certificate companies	0001193125-14-055104.pdf 0001193125-14-055104.rtf 0001193125-14-055104.xls View HTML
March 4, 2014	S-1/A	Amended Registration statement for face-amount certificate companies	0001193125-14-081000.pdf 0001193125-14-081000.rtf 0001193125-14-081000.xls View HTML
March 7, 2014	S-1/A	Amended Registration statement for face-amount certificate companies	0001193125-14-087673.pdf 0001193125-14-087673.rtf 0001193125-14-087673.xls View HTML
March 7, 2014	S-1/A	Amended Registration statement for face-amount certificate companies	0001193125-14-089411.pdf 0001193125-14-089411.rtf 0001193125-14-089411.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax